Analyst Reco. Vaxcyte, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-04-10 pm EDT			5-day change	1st Jan Change
60.88 ^USD	-1.31%		+4.28%	+31.95%

Mar. 30	Certain Common Stock of Vaxcyte, Inc. are subject to a Lock-Up Agreement Ending on 31-MAR-2026.	CI
Mar. 30	Certain Pre-funded warrants of Vaxcyte, Inc. are subject to a Lock-Up Agreement Ending on 31-MAR-2026.	CI

Feb. 25	Analyst recommendations: IBM, Axon, Caterpillar, Fair Isaac, Gilead…
25-10-16	Analyst recommendations: Las Vegas Sands, Alphabet, Applovin, Carmax, United AIrlines…
25-05-08	Analyst recommendations: AMD, Walt Disney, Applovin, Ionq, Uber...
25-04-01	Analyst recommendations: Autozone, Block, Ulta Beauty, Lululemon…
25-03-31	Needham Cuts Price Target on Vaxcyte to $90 From $140, Maintains Buy Rating	MT
24-09-10	Analyst recommendations: Apple, Oracle, Progressive, Dollar Tree...
24-09-10	Mizuho Boosts Price Target on Vaxcyte to $163 From $113, Maintains Outperform Rating	MT
24-03-12	Mizuho Adjusts Price Target on Vaxcyte to $113 From $69, Maintains Buy Rating	MT
24-02-28	Needham Raises Price Target on Vaxcyte to $95 From $73, Maintains Buy Rating	MT
23-12-07	Mizuho Initiates Vaxcyte With Buy Rating, Price Target is $69	MT
23-04-18	TD Cowen Starts Vaxcyte at Outperform	MT
23-04-18	BofA Securities Adjusts Price Target on Vaxcyte to $68 From $63, Keeps Buy Rating	MT
23-02-28	Guggenheim Adjusts Price Target on Vaxcyte to $65 From $66, Maintains Buy Rating	MT
23-01-03	Needham Adjusts Price Target on Vaxcyte to $58 From $52, Maintains Buy Rating	MT
22-12-16	SVB Securities Initiates Vaxcyte With Outperform Rating, Sets Price Target at $60	MT
22-12-15	Guggenheim Initiates Vaxcyte at Buy With $66 Price Target	MT
22-11-17	BTIG Starts Vaxcyte at Buy With $69 Price Target	MT